{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:14:11Z","timestamp":1794003251131,"version":"4.8.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12891-019-2486-3","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:02:39Z","timestamp":1553932959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Investigating the effects of Pirfenidone on TGF-\u03b21 stimulated non-SMAD signaling pathways in Dupuytren\u2019s disease -derived fibroblasts"],"prefix":"10.1186","volume":"20","author":[{"given":"Chaoming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Baratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kathju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Satish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"2486_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","volume":"4","author":"S Hindocha","year":"2009","unstructured":"Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren\u2019s disease incidence and prevalence rates in relation to etiology. Hand (NY). 2009;4:256\u201369.","journal-title":"Hand (NY)"},{"key":"2486_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","volume":"132","author":"R Lanting","year":"2013","unstructured":"Lanting R, van den Heuvel ER, Westerink B, Werker PM. Prevalence of Dupuytren disease in the Netherlands. Plast Reconstr Surg. 2013;132:394\u2013403.","journal-title":"Plast Reconstr Surg"},{"key":"2486_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1753193414535720","volume":"40","author":"S Larsen","year":"2015","unstructured":"Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren\u2019s disease: a study of 30,330 Danish twin pairs. J Hand Surg Eur. 2015;40:171\u20136.","journal-title":"J Hand Surg Eur"},{"issue":"957","key":"2486_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/pgmj.2004.027425","volume":"81","author":"MG Hart","year":"2005","unstructured":"Hart MG, Hooper G. Clinical associations of Dupuytren\u2019s disease. Postgrad Med J. 2005;81(957):425\u20138.","journal-title":"Postgrad Med J"},{"key":"2486_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2106\/00004623-200701000-00026","volume":"89","author":"GM Rayan","year":"2007","unstructured":"Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007;89:189\u201398.","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"2486_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000001425","volume":"5","author":"C Zhou","year":"2017","unstructured":"Zhou C, Hovius SER, Pieters AJ, Slijper HP, Feitz R, Selles RW. Comparative effectiveness of needle Aponeurotomy and collagenase injection for Dupuytren's contracture: a multicenter study. Plast Reconstr Surg Glob Open. 2017;5(9):e1425.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2486_CR7","doi-asserted-by":"crossref","unstructured":"Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J. CORD I Study group injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture. N Engl J Med 2009; 361:968\u2013979.","DOI":"10.1056\/NEJMoa0810866"},{"key":"2486_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","volume":"129","author":"AL Rijssen van","year":"2012","unstructured":"van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren\u2019s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129:469\u201377.","journal-title":"Plast Reconstr Surg"},{"key":"2486_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s11552-011-9326-8","volume":"6","author":"NC Chen","year":"2011","unstructured":"Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren\u2019s contracture. Hand (N Y). 2011;6:250\u20135.","journal-title":"Hand (N Y)"},{"key":"2486_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0363-5023(05)80105-4","volume":"20","author":"J Tomasek","year":"1995","unstructured":"Tomasek J, Rayan GM. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren\u2019s disease fibroblasts. J Hand Surg Am. 1995;20:450\u20135.","journal-title":"J Hand Surg Am"},{"key":"2486_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0363-5023(96)80317-0","volume":"21","author":"GM Rayan","year":"1996","unstructured":"Rayan GM, Parizi M, Tomasek JJ. Pharmacologic regulation of Dupuytren\u2019s fibroblast contraction in vitro. J Hand Surg Am. 1996;21:1065\u201370.","journal-title":"J Hand Surg Am"},{"issue":"1","key":"2486_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0749-0712(21)00437-6","volume":"15","author":"MA Badalamente","year":"1999","unstructured":"Badalamente MA, Hurst LC. The biochemistry of Dupuytren\u2019s disease. Hand Clin. 1999;15(1):35\u201342 v-vi.","journal-title":"Hand Clin"},{"issue":"3","key":"2486_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.hcl.2018.03.001","volume":"34","author":"AY Zhang","year":"2018","unstructured":"Zhang AY, Kargel JS. The basic science of Dupuytren disease. Hand Clin. 2018;34(3):301\u20135.","journal-title":"Hand Clin"},{"key":"2486_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1755-1536-4-14","volume":"4","author":"C Krause","year":"2011","unstructured":"Krause C, Kloen P, Ten Dijke P. Elevated transforming growth factor b and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren\u2019s disease fibroblasts. Fibrogenesis Tissue Repair. 2011;4:14.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"6","key":"2486_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3109\/03008207.2012.686542","volume":"53","author":"K Ratajczak-Wielgomas","year":"2012","unstructured":"Ratajczak-Wielgomas K, Gosk J, Rabczy\u0144ski J, Augoff K, Podhorska-Oko\u0142\u00f3w M, Gamian A, Rutowski R. Expression of MMP-2, TIMP-2, TGF-\u03b21, and decorin in Dupuytren\u2019s contracture. Connect Tissue Res. 2012;53(6):469\u201377.","journal-title":"Connect Tissue Res"},{"key":"2486_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2474-12-113","volume":"12","author":"L Satish","year":"2011","unstructured":"Satish L, Gallo PH, Baratz ME, Johnson S, Kathju S. Reversal of TGF-\u03b21 stimulation of \u03b1-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts. BMC Musculoskelet Disord. 2011;12:113.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"2486_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1006\/excr.2000.4869","volume":"257","author":"MB Vaughan","year":"2000","unstructured":"Vaughan MB, Howard EW, Tomasek JJ. Transforming growth factor-beta1 promoted the morphological and functional differentiation of the myofibroblast. Exp Cell Res. 2000;257(1):180\u20139.","journal-title":"Exp Cell Res"},{"issue":"3","key":"2486_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/sj.jid.5700613","volume":"127","author":"B Hinz","year":"2007","unstructured":"Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007;127(3):526\u201337.","journal-title":"J Invest Dermatol"},{"key":"2486_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2486_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jhsa.2009.02.008","volume":"34","author":"MA Bisson","year":"2009","unstructured":"Bisson MA, Beckett KS, McGrouther DA, Grobbelaar AO, Mudera V. Transforming growth factor-beta1 stimulation enhances Dupuytren\u2019s fibroblast contraction in response to unizxial mechanical load within a 3-dimensional collagen gel. J Hand Surg Am. 2009;34(6):1102\u201310.","journal-title":"J Hand Surg Am"},{"key":"2486_CR21","doi-asserted-by":"crossref","unstructured":"Zhou C, Liu F, Gallo PH, Baratz ME, Kathju S, Satish L. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts. BMC Musculoskelet Disord 2016; 17(1):469.","DOI":"10.1186\/s12891-016-1326-y"},{"issue":"4","key":"2486_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","volume":"28","author":"MA Bisson","year":"2003","unstructured":"Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO. The different characteristics of Dupuytren\u2019s disease fibroblast derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg Br. 2003;28(4):351\u20136.","journal-title":"J Hand Surg Br"},{"key":"2486_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","volume":"21","author":"XH Feng","year":"2005","unstructured":"Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol. 2005;21:659\u201393.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2486_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-Smad pathways in TGF-\u03b2 signaling. Cell Res. 2009;19:128\u201339.","journal-title":"Cell Res"},{"issue":"1","key":"2486_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40267-017-0459-x","volume":"34","author":"KA Lyseng-Williamson","year":"2018","unstructured":"Lyseng-Williamson KA. Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use. Drugs Ther Perspect. 2018;34(1):8\u201315.","journal-title":"Drugs Ther Perspect"},{"issue":"6","key":"2486_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/J.JHSB.2005.07.002","volume":"30","author":"A Cordova","year":"2005","unstructured":"Cordova A, Tripoli M, Corradino B, Napoli N, Moschella M. Dupuytren\u2019s contracture: an update review of biomolecular aspects and therapeutic perspectives. J Hand Surg (Br). 2005;30(6):557\u201362.","journal-title":"J Hand Surg (Br)"},{"issue":"5","key":"2486_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2106\/00004623-198163050-00014","volume":"63","author":"D Brickley-Parsons","year":"1981","unstructured":"Brickley-Parsons D, Glimcher MJ, Smith RJ, Albin R, Adams JP. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren\u2019s disease. J Bone Joint Surg Am. 1981;63(5):787\u201397.","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"2486_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1620\/tjem.142.437","volume":"142","author":"T Hanyu","year":"1984","unstructured":"Hanyu T, Tajima T, Takagi T, Sasaki S, Fujimoto D, Isemura M, Yosizawa Z. Biochemical studies on the collagen of the palmar aponeurosis affected with Dupuytren\u2019s disease. Tohuku J Exp Med. 1984;142(4):437\u201343.","journal-title":"Tohuku J Exp Med"},{"issue":"4","key":"2486_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1753193410362848","volume":"35","author":"WL Lam","year":"2010","unstructured":"Lam WL, Rawlins JM, Karoo ROS, Naylor I, Sharpe DT. Re-visiting Luck\u2019s classification: a histological analysis of Dupuytren\u2019s disease. J Hand Surg Eur Vol. 2010;35(4):312\u20137.","journal-title":"J Hand Surg Eur Vol"},{"issue":"18","key":"2486_CR30","first-page":"30038","volume":"S0098\u20132997","author":"R Weiskirchen","year":"2018","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2018;S0098\u20132997(18):30038\u201340.","journal-title":"Mol Aspects Med"},{"key":"2486_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-3-1","volume":"3","author":"J Macias-Barragan","year":"2010","unstructured":"Macias-Barragan J, Sandoval-Rodriguez A, Navarro-Partida J, Armendariz-Borunda J. The multifaceted role of pirfenidone and its novel targets. Fibrogenesis Tissue Repair. 2010;3:1. https:\/\/doi.org\/10.1186\/1755-1536-3-1 .","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"1","key":"2486_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12890-018-0626-4","volume":"18","author":"M Molina-Molina","year":"2018","unstructured":"Molina-Molina M, Machahua-Huamani C, Vicens-Zygmunt V, Llatj\u00f3s R, Escobar I, Sala-Llinas E, Luburich-Hernaiz P, Dorca J, Montes-Worboys A. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells. BMC Pulm Med. 2018;18(1):63.","journal-title":"BMC Pulm Med"},{"issue":"2","key":"2486_CR33","doi-asserted-by":"publisher","first-page":"e0172592","DOI":"10.1371\/journal.pone.0172592","volume":"12","author":"T Stahnke","year":"2017","unstructured":"Stahnke T, Kowtharapu BS, Stachs O, Schmitz KP, Wurm J, Wree A, Guthoff RF, Hovakimyan M. Suppression of TGF-\u03b2 pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro. PLoS One. 2017;12(2):e0172592.","journal-title":"PLoS One"},{"issue":"4","key":"2486_CR34","first-page":"3907","volume":"18","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhang Y, Chi P. Pirfenidone suppresses TGF-\u03b21-induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K\/AKT signaling pathway. Mol Med Rep. 2018;18(4):3907\u201313.","journal-title":"Mol Med Rep"},{"issue":"5","key":"2486_CR35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41374-017-0014-3","volume":"98","author":"CL Hall","year":"2018","unstructured":"Hall CL, Wells AR, Leung KP. Pirfenidone reduces profibrotic responses in human dermal myofibroblasts, in vitro. Lab Investig. 2018;98(5):640\u201355.","journal-title":"Lab Investig"},{"issue":"8","key":"2486_CR36","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","volume":"8","author":"Y Mebratu","year":"2009","unstructured":"Mebratu Y, Tesfaigzi Y. How ERK1\/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle. 2009;8(8):1168\u201375.","journal-title":"Cell Cycle"},{"key":"2486_CR37","doi-asserted-by":"crossref","unstructured":"Roux PP, Blenis J ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004 68 (2):320\u2013344.","DOI":"10.1128\/MMBR.68.2.320-344.2004"},{"issue":"23","key":"2486_CR38","first-page":"6025","volume":"274","author":"D New","year":"2007","unstructured":"New D, Wu K, Kwok AW. Wong YH. G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis FEBS J. 2007;274(23):6025\u201336 Epub 2007 Oct 19.","journal-title":"G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis FEBS J"},{"key":"2486_CR39","doi-asserted-by":"crossref","unstructured":"Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, grehn F, Schlunck G, Knaus P. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Opthalmol Vis Sci 2006; 47:1500\u20131509.","DOI":"10.1167\/iovs.05-0361"},{"key":"2486_CR40","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/jid.2008.39","volume":"128","author":"AM Bujor","year":"2008","unstructured":"Bujor AM, Pannu J, Bu S, Smith EA, Muise-Helmericks RC, Trojanowska M. Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. H Invest Dermatol. 2008;128:1906\u201314.","journal-title":"H Invest Dermatol"},{"issue":"4","key":"2486_CR41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1159\/000341470","volume":"30","author":"I Ratkaj","year":"2012","unstructured":"Ratkaj I, Bujak M, Juri\u0161i\u0107 D, Baus Lon\u010dar M, Bendelja K, Paveli\u0107 K, Kraljevi\u0107 PS. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-\u03b2 inducible p38 MAPK pathway. Cell Physiol Biochem. 2012;30(4):927\u201342.","journal-title":"Cell Physiol Biochem"},{"key":"2486_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","volume":"22","author":"Y Fukata","year":"2001","unstructured":"Fukata Y, Amano M, Kaibuchi K. Rho-rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22:32\u20139.","journal-title":"Trends Pharmacol Sci"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-019-2486-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-019-2486-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T21:45:26Z","timestamp":1663191926000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-019-2486-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2486"],"URL":"https:\/\/doi.org\/10.1186\/s12891-019-2486-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DD cord and CT fascial tissues were obtained during surgical resection from Division of Upper Extremity Surgery, Department of Orthopaedic Surgery, Allegheny General Hospital, Pittsburgh, PA. Allegheny-Singer Research Institute\u2019s Institutional Review Board (IRB protocol no. RC-4040) approved the protocol. Before the surgical procedure, all subjects signed the written informed consent forms. The study protocol strictly conformed to the ethical guidelines of the 1975 Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"135"}}